Feng Mu

Biography

Ph.D Genomics from Chinese Academy of Sciences, Rotating CEO of BGI Dr. Mu has held various leadership positions in BGI since 1998. He was appointed to be the rotating CEO of BGI in 2017. In 1999, Dr Mu participated in several projects, such as the human genome project. Dozens of results of his research projects have been published on Nature, PLOS Genetics, Gigasceince and other prestigious journals. Also, he devoted himself into the establishments of BGI sci-tech service platform, the instrument production platform，and the medical service platform. The genomics-based services and solutions he developed, such as diagnose kits for early detection of SARS and Ebola during their outbreak helped slow down spread of pandemic. Dr. Mu obtained 10 patents from State Intellectual Property Office of the P.R.China. He devotes himself and his leadership in BGI to promote industrialization and marketization of transomics solutions, using NGS (next-generation sequencing) technology on human diseases diagnosis (e.g. NIFTY and HearingCare test), and introduces these clinical tests rural areas in China.

Research Interest

Business, Management, Toxicology, Pharmacology